Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
Gregory Renza Downgraded (AVTX) to Hold and Decreased Target to $180 on, Jun 27th, 2023
Gregory Renza of RBC Capital, Downgraded "Avalo Therapeutics, Inc." (AVTX) to Hold and Decreased Target from $2,160 to $180 on, Jun 27th, 2023.
Gregory, nor any peers, have made any analyst calls on AVTX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30